Anúncio
Anúncio

ITRM

ITRM logo

Iterum Therapeutics plc Ordinary Share

0.36
USD
Patrocinado
+0.01
+2.80%
07 de jan., 15:58 UTC -5
Encerrado
exchange

Pós-Mercado

0.37

+0.01
+2.50%

Relatórios de Lucros ITRM

Rácio de surpresa positiva

ITRM separação 17 de 29 últimas estimativas.

59%

Próximo Relatório

Data do Próximo Relatório
05 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.07M
/
-$0.09
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+685.92%
/
-55.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-60.87%

Iterum Therapeutics plc Ordinary Share earnings per share and revenue

On 14 de nov. de 2025, ITRM reported earnings of -0.20 USD per share (EPS) for Q3 25, missing the estimate of -0.11 USD, resulting in a -78.25% surprise. Revenue reached 390.00 mil, compared to an expected --, with a 0.00% difference. The market reacted with a -16.11% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.09 USD, with revenue projected to reach 3.07 milhão USD, implying an diminuir of -55.00% EPS, and aumentar of 685.92% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Iterum Therapeutics plc Ordinary Share reported EPS of -$0.20, missing estimates by -78.25%, and revenue of $390.00K, 0% as expectations.
The stock price moved down -16.11%, changed from $0.56 before the earnings release to $0.47 the day after.
The next earning report is scheduled for 05 de fev. de 2026.
Based on 4 analistas, Iterum Therapeutics plc Ordinary Share is expected to report EPS of -$0.09 and revenue of $3.07M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio